Ocular Therapeutix, Inc.
OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

Last updated:

Abstract:

The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.

Status:
Application
Type:

Utility

Filling date:

24 Mar 2021

Issue date:

7 Oct 2021